Intravitreal Aflibercept Injection (IAI) for Presumed Ocular

See also
Status	Clinical Trial	Phase
Completed	`NCT01908816` - An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.	Phase 3
Completed	`NCT02015351` - Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study	N/A
Withdrawn	`NCT01666236` - Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy	Phase 4
Completed	`NCT01175395` - 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)	Phase 1/Phase 2
Terminated	`NCT00712491` - Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration	Phase 1/Phase 2
Completed	`NCT00533520` - Evaluation of Dosing Interval of Higher Doses of Ranibizumab	Phase 4
Completed	`NCT00242580` - A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib	Phase 3
Completed	`NCT04075188` - Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid	N/A
Not yet recruiting	`NCT05055973` - OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT.
Recruiting	`NCT00568191` - Stratus Versus Cirrus OCT in AMD	N/A
Completed	`NCT01256632` - Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy	N/A
Recruiting	`NCT00100087` - Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System	Phase 1/Phase 2
Completed	`NCT04455399` - Time Efficiency Comparison of Two IntraVitreal Injection Techniques	N/A
Terminated	`NCT02857894` - Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)
Not yet recruiting	`NCT02934841` - Conbercept in Choroidal Neovascularization Secondary to Uveitis	Phase 2
Completed	`NCT01880788` - Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD	N/A
Completed	`NCT00775411` - Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)	Phase 2
Completed	`NCT00604071` - Sensitivity of the Home Macular Perimeter (HMP)	N/A
Completed	`NCT00406250` - Intravitreal Bevacizumab in Agioid Streaks	Phase 1
Withdrawn	`NCT00403156` - Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration	Phase 1

NCT number	NCT01578720
Study type	Interventional
Source	Retina Research Institute, LLC
Contact
Status	Completed
Phase	Phase 1
Start date	June 2012
Completion date	March 2015

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms